OKUR
OnKure Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.78
+0.26 ▲ +7.39%
🌙 3월 13일 7:42 PM ET (한국 3/14 08:42)
$3.80
+0.02 ▲ +0.53%
| Index | - | P/E | - | EPS (ttm) | -4.4 | Insider Own | 40.38% | Shs Outstand | 0.01B | Perf Week | 23.93% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | 0.77% | Insider Trans | -0.01% | Shs Float | 0.01B | Perf Month | 53.66% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | -0.91 | Inst Own | 52.99% | Short Float | 0.67% | Perf Quarter | 8.93% |
| Income | -0.06B | P/S | - | EPS this Y | 25.91% | Inst Trans | -12.05% | Short Ratio | 0.48 | Perf Half Y | 54.92% |
| Sales | 0.00B | P/B | 0.92 | EPS next 5Y | 12.33% | ROA | -67.24% | Short Interest | 0.05M | Perf YTD | 30.34% |
| Book/sh | 4.11 | P/C | 0.88 | EPS past 3/5Y | 40.79% 11.29% | ROE | -74.39% | 52W High | -28.41% ($5.28) | Perf Year | -18.18% |
| Cash/sh | 4.32 | P/FCF | - | Sales past 3/5Y | - | ROIC | -105.93% | 52W Low | 122.35% ($1.70) | Perf 3Y | -91.27% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 46.2% | Gross Margin | - | Volatility(W/M) | 9.49% 8.86% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.27 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 10.28 | EPS Q/Q | 63.95% | Profit Margin | - | RSI (14) | 76.41 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.28 | Sales Q/Q | - | SMA20 | 29.12% ($2.93) | Beta | 0.34 | Target Price | $24.25 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 3000000 | SMA50 | 32.86% ($2.85) | Rel Volume | 2.42 | Prev Close | $3.52 |
| Employees | 45 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 14.06% - | SMA200 | 37.51% ($2.75) | Avg Volume(3M) | 0.11M | Price | $3.78 |
| IPO | 2021/4/9 | Option/Short | No/Yes | Trades | 1951 | Volume | 272,261 | Change | 7.39% |
뉴스 로딩 중...